Interaction Checker

Omega-3-acid ethyl esters interactions

Omega-3-acid ethyl esters (Lovaza), an omega-3 fatty acid has 11 documented interactions across the FDA labels and fact sheets we index: 0 major, 10 moderate, 1 minor, and 0 where a label reports no significant interaction. Each entry below quotes the sentence behind it. This drug page is a starting point, not a verdict for your situation.

Interactions from the label

Moderate interactions (10)

  • ApixabananticoagulantModerate

    Patients taking omega-3-acid ethyl esters capsules and an anticoagulant or other drug affecting coagulation (e.g., anti-platelet agents) should be monitored periodically. (Omega-3-acid ethyl esters label, Drug interactions)

  • ArgatrobananticoagulantModerate

    Patients taking omega-3-acid ethyl esters capsules and an anticoagulant or other drug affecting coagulation (e.g., anti-platelet agents) should be monitored periodically. (Omega-3-acid ethyl esters label, Drug interactions)

  • BivalirudinanticoagulantModerate

    Patients taking omega-3-acid ethyl esters capsules and an anticoagulant or other drug affecting coagulation (e.g., anti-platelet agents) should be monitored periodically. (Omega-3-acid ethyl esters label, Drug interactions)

  • DabigatrananticoagulantModerate

    Patients taking omega-3-acid ethyl esters capsules and an anticoagulant or other drug affecting coagulation (e.g., anti-platelet agents) should be monitored periodically. (Omega-3-acid ethyl esters label, Drug interactions)

  • EdoxabananticoagulantModerate

    Patients taking omega-3-acid ethyl esters capsules and an anticoagulant or other drug affecting coagulation (e.g., anti-platelet agents) should be monitored periodically. (Omega-3-acid ethyl esters label, Drug interactions)

  • EnoxaparinanticoagulantModerate

    Patients taking omega-3-acid ethyl esters capsules and an anticoagulant or other drug affecting coagulation (e.g., anti-platelet agents) should be monitored periodically. (Omega-3-acid ethyl esters label, Drug interactions)

  • FondaparinuxanticoagulantModerate

    Patients taking omega-3-acid ethyl esters capsules and an anticoagulant or other drug affecting coagulation (e.g., anti-platelet agents) should be monitored periodically. (Omega-3-acid ethyl esters label, Drug interactions)

  • HeparinanticoagulantModerate

    Patients taking omega-3-acid ethyl esters capsules and an anticoagulant or other drug affecting coagulation (e.g., anti-platelet agents) should be monitored periodically. (Omega-3-acid ethyl esters label, Drug interactions)

  • RivaroxabananticoagulantModerate

    Patients taking omega-3-acid ethyl esters capsules and an anticoagulant or other drug affecting coagulation (e.g., anti-platelet agents) should be monitored periodically. (Omega-3-acid ethyl esters label, Drug interactions)

  • WarfarinanticoagulantModerate

    Patients taking omega-3-acid ethyl esters capsules and an anticoagulant or other drug affecting coagulation (e.g., anti-platelet agents) should be monitored periodically. (Omega-3-acid ethyl esters label, Drug interactions)

Minor mentions (1)

  • Fish oil (omega-3)Herbal and supplementMinor

    Fish Allergy Omega-3-acid ethyl esters capsules contains ethyl esters of omega-3 fatty acids (EPA and DHA) obtained from the oil of several fish sources. (Omega-3-acid ethyl esters label, Warnings and precautions)

Check Omega-3-acid ethyl esters against everything you take. Add your full list; every pair is checked at once.

Open in the checker

Not medical advice. Severity reflects the label's wording, not your circumstances. A "major" flag can be routine under supervision and a "minor" one can matter at high doses. Ask a pharmacist.